Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Achieving cervical cancer elimination: The simulated impacts of HPV vaccination and transitioning from liquid-based cytology to HPV-based screening test. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2020 · External reference
Malaysia National cancer registry report (MNCR).
2019 · External reference
Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme.
10.1186/s12889-018-6316-6 · 2018 · External reference
Unresolved reference
2021 · External reference
The Implementation of a Primary HPV Self-Testing Cervical Screening Program in Malaysia through Program ROSE—Lessons Learnt and Moving Forward.
10.3390/curroncol29100579 · 2022 · External reference
Unresolved reference
2021 · External reference
Unresolved reference
2019 · External reference
Knowledge and barriers towards cervical cancer screening among young women in Malaysia.
2010 · External reference
Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
2009 · External reference
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
10.1016/s0140-6736(13)62218-7 · 2014 · External reference
Interventions to improve the uptake of cervical cancer screening among lower socioeconomic groups: a systematic review.
10.1016/j.ypmed.2017.11.019 · 2018 · External reference
Interventions to improve cervical cancer screening uptake amongst young women: a systematic review.
10.3109/0284186x.2013.869618 · 2014 · External reference
Prevalence and sociodemographic predictors of high-risk vaginal Human Papillomavirus Infection: findings from a public cervical cancer screening registry.
2023 · External reference
The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support.
10.1002/ijc.33759 · 2021 · External reference
Introduction to system dynamic modelling and vensim software: UUM Press.
2017 · External reference
Cost-effectiveness analysis for HPV mitigation strategies in the Republic of Moldova based on infectious disease modelling.
2019 · External reference
System dynamics model of cervical cancer vaccination and screening interventions in Kenya.
2014 · External reference
Using system dynamics to help develop and implement policies and programmes in health care in England.
10.1002/(sici)1099-1727(199923)15:3<293::aid-sdr169>3.0.co;2-1 · 1999 · External reference
Industrial dynamics.
10.1057/palgrave.jors.2600946 · 1997 · External reference
System dynamics modeling for public health: background and opportunities.
10.2105/ajph.2005.062059 · 2006 · External reference
Feedback thought in social science and systems theory.
1991 · External reference
Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.
10.1093/aje/kwt077 · 2013 · External reference
System dynamics modeling: tools for learning in a complex world.
10.2307/41166098 · 2001 · External reference
Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years.
10.1186/1471-2458-10-734 · 2010 · External reference
Cervical cancer screening in partly HPV vaccinated cohorts–A cost-effectiveness analysis.
10.1371/journal.pone.0145548 · 2016 · External reference
Human papillomavirus and cervical cancer.
10.1016/s0140-6736(07)61416-0 · 2007 · External reference
Human Papillomavirus and Related Diseases in Malaysia. Summary Report.
2023 · External reference
Prophylactic HPV vaccination: past, present, and future.
10.1017/s0950268815002198 · 2016 · External reference
Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: a randomized, placebo-controlled trial with 78-month follow-up.
10.1016/j.vaccine.2018.08.009 · 2019 · External reference
Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program.
10.1371/journal.pone.0278477 · 2022 · External reference
M.o.H.M. Human Papillomavirus (Types 16, 18)
2023 · External reference
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.
10.1016/s2468-2667(16)30001-9 · 2016 · External reference
Unresolved reference
2015 · External reference
Unresolved reference
2011 · External reference
National Health and Morbidity Survey 2019 (NHMS 2019) Volume II: Healthcare Demand.
2020 · External reference
Cost Analysis of Human Papillomavirus Test and Pap Smear Test in Ministry of Health Malaysia.
2023 · External reference
GDP deflator (base year varies by country)–Malaysia.
2023 · External reference
Unresolved reference
2018 · External reference
Unresolved reference
2023 · External reference
HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control.
10.1016/j.pvr.2019.100184 · 2019 · External reference
Industrial and business forecasting methods: A practical guide to exponential smoothing and curve fitting.
1982 · External reference
On the relationship among values of the same summary measure of error when used across multiple characteristics at the same point in time: an examination of MALPE and MAPE.
2015 · External reference
Cancer incidence in five continents.
1966 · External reference
Cancer mortality for selected sites in 24 countries (1950–1957).
1960 · External reference
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
10.1016/s0140-6736(20)30068-4 · 2020 · External reference
Unresolved reference
2023 · External reference
Human papillomavirus vaccines: WHO position paper.
2022 · External reference
The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
10.1016/j.ygyno.2018.10.045 · 2019 · External reference
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in A ustralia, a high vaccination coverage country.
10.1002/ijc.30926 · 2017 · External reference
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: example from Australia.
10.1371/journal.pone.0185332 · 2018 · External reference
Ministry Health Malaysia
2023 · External reference
Unresolved reference
2021 · External reference
Cost‐effectiveness of HPV‐based cervical screening based on first year results in the Netherlands: a modelling study.
10.1111/1471-0528.16400 · 2021 · External reference
Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials.
10.1016/j.ejca.2015.07.006 · 2015 · External reference
